Navigation Links
BioLife Solutions Announces Strategic Partnership with HemaCare
Date:6/25/2013

BOTHELL, Wash., June 25, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, (OTCPK:HEMA), a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic relationship wherein HemaCare will market BioLife's HypoThermosol® and CryoStor® biopreservation media products and HemaCare's blood derived cells to the research and clinical communities.

(Logo: http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO)

Pete van der Wal, President and CEO of HemaCare, remarked on the extended shelf life and viability of HemaCare's Bioresearch products, specifically, peripheral blood mononuclear cells (PBMNC's), through the use of BioLife's HypoThermosol storage and shipping medium, "The current gold standard of shipping frozen PBMNC's to researchers requires back-end thawing and culturing before the cells are ready for use.  HypoThermosol has demonstrated remarkable ability to extend the shelf life of this valuable cell type out to 4 days, eliminating the cryopreservation process and its related yield loss, and enabling a worldwide delivery footprint for fresh apheresis-derived cells."

Information on the use of HypoThermosol with HemaCare's
'/>"/>

SOURCE BioLife Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
2. BioLife Solutions 2011 Revenue Up 33%
3. BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board
4. Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION
5. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
6. BioLife Solutions Announces 2012 Second Quarter Results: Eighth Straight Quarter of Record Revenue
7. BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference
8. BioLife Solutions Announces 2012 Third Quarter Results: Ninth Straight Quarter of Record Revenue
9. BioLife Solutions Announces License Agreement
10. BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013
11. BioLife Solutions Named One of Washingtons Best Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... BioNorth Texas (BioNorthTX), an independent, non-profit ... sciences industry in northern region of Texas, held ... Foundry in Dallas on April 27, 2015. The ... broad spectrum of biotech professionals from the North ... in partnering with key life sciences organizations both ...
(Date:5/28/2015)... RXi Pharmaceuticals Corporation (NASDAQ: RXII ), ... therapeutics, primarily in the areas of dermatology and ophthalmology, ... 26 million units at a price to the public ... $10.4 million. Each unit consists of (i) one share ... to purchase 0.50 of a share of common stock ...
(Date:5/28/2015)...  GenVec, Inc. (Nasdaq: GNVC ) today announced ... , will present a company overview at the Jefferies ... Thursday, June 4, 2015. The live ... available at the following link:  http://wsw.com/webcast/jeff88/gnvc .  This ... access, visit www.genvec.com , click on "Investors and ...
(Date:5/28/2015)... Fertility Centers of New England is proud to announce ... a new and expanded role as Medical Director. In ... and quality assurance for the practice. , “We are ... experienced reproductive endocrinologists,” said Fertility Centers of New England ... and compassionate, individualized care have helped set FCNE apart ...
Breaking Biology Technology:BioNorthTX Holds Inaugural Board of Directors Meeting 2BioNorthTX Holds Inaugural Board of Directors Meeting 3RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3GenVec To Present At The Jefferies Healthcare Conference 2Danielle Vitiello, MD of Fertility Centers of New England, Named New Medical Director 2
... on terror includes fighting the dark side of deadly ... Raushel is helping with the fight by developing an ... organophosphates. , Synthetic organophosphates started their journey as insecticides ... the dangerous alleys of chemical warfare during World War ...
... team are researching nano-scale cantilevers that have the potential to ... the air. Put them into a small handheld device and ... in industry, in health care and even at home. , ... work has been something we,ve only seen so far in ...
... Although naturally occurring smallpox was eradicated in 1977, ... a laboratory and release it into the population. Under ... insufficient for universal administration. In a study published in ... of Medicine , researchers found that lifetime protection is ...
Cached Biology Technology:Researcher working on destruction of chemical weapons 2Clemson researchers advance nanoscale electromechanical sensors 2New study indicates smallpox vaccination effective for decades 2
(Date:5/22/2015)... , May 22, 2015 According ... by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, ... (Government and Utilities, Consumer and Home) - Global Forecast ... grow from $2.77 Billion in 2015 to $6.19 Billion ... Browse 79 market data Tables and   43 ...
(Date:5/21/2015)... , May 21, 2015 The Sync ... of music for health, today announced a collaborative partnership ... The partnership will center on collaboration on original research, ... first step in the collaboration, The Sync Project and ... "Music as Medicine" in the 2015-2016 academic year.  ...
(Date:5/20/2015)... , May 20, 2015 NXT-ID, Inc. ... that its wholly owned subsidiary, 3D-ID LLC, a company ... Team Battelle for the biometrics technology portion of the ... Contract from the Department of the Army. ... products developed for government, law enforcement and security agencies. ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... Cincinnati (UC) have identified key molecular components linking circadian ... , providing insights that could lead to improved disease ... the UC College of Medicine Department of Molecular and ... findings Monday, Jan. 13, online ahead of print in ...
... of Illinois study has identified the three most significant risk ... a parental BMI that classifies the mom or dad as ... eating in order to control his weight. "We looked ... of child obesity, and the three that emerged as strong ...
... concentrations of serum long-chain omega-3 fatty acids may help reduce ... of Eastern Finland study published recently in Diabetes Care ... fish oils. Type 2 diabetes is becoming increasingly widespread ... risk factor, which means that diet and other lifestyle factors ...
Cached Biology News:Researchers identify key components linking circadian rhythms and cell division cycles 2Illinois study identifies 3 risk factors most highly correlated with child obesity 2Fish derived serum omega-3 fatty acids help reduce the risk of type 2 diabetes 2
Sheep polyclonal to Trenbolone ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule: 17 alpha Trenbolone(3)-BTG....
... chain (human), clone 41D GenBank ... : Native clusterin purified from human ... 0.15M NaCl and 0.05% sodium azide ... lysates from HeLa cells or MCF-7 ...
Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...
Chlamydia pneumoniae (TWAR)...
Biology Products: